What CorMedix (CRMD) Investors Need to Know Today

Shares of Small-cap health care company CorMedix moved 16.8% this afternoon, and are now trading at $5.18 per share. The average analyst target price for the stock is $16.67.

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally.

Based on its trailing earning per share of -0.63, CorMedix has a trailing 12 month Price to Earnings (P/E) ratio of -8.2 CRMD has a forward P/E ratio of -5.8 based on its earnings guidance of None.

CRMD Has an Exceptionally Strong Balance Sheet

2019-12-31 2020-12-31 2021-12-31 2022-12-31
Revenue (k) $283 $239 $191 $65
Operating Margins -7416.3% -11378.4% -15417.5% -46819.9%
Net Margins -5801.29% -9207.7% -14774.7% -45409.9%
Net Income (k) -$16,433 -$22,028 -$28,210 -$29,702
Net Interest Income -$465 $83 -$2 $300
Depreciation & Amort. -$73 -$128 -$62 -$85
Earnings Per Share -$1.8 -$0.77 -$0.75 -$0.63
EPS Growth n/a 57.22% 2.6% 16.0%
Diluted Shares (k) 24,152 28,562 37,666 41,282
Free Cash Flow (k) -$15,052 -$21,968 -$21,155 -$24,357
Capital Expenditures -$37 -$113 -$1,425 -$219
Net Current Assets (k) $23,519 $43,097 $60,321 $52,573
Current Ratio 5.04 11.58 12.44 9.44
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.